{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T08:21:57Z","timestamp":1787732517806,"version":"build-2784847793"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","diabetesresearchclinicalpractice.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.diabres.2020.108591","type":"journal-article","created":{"date-parts":[[2020,12,10]],"date-time":"2020-12-10T05:07:15Z","timestamp":1607576835000},"page":"108591","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Moderation of the effect of glycemia on the risk of cardiovascular disease in type 1 diabetes: The DCCT\/EDIC study"],"prefix":"10.1016","volume":"171","author":[{"given":"Ionut","family":"Bebu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara H.","family":"Braffett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trevor J.","family":"Orchard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gayle M.","family":"Lorenzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Nathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William H.","family":"Herman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M.","family":"Lachin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.diabres.2020.108591_b0005","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.2337\/dc06-1161","article-title":"Type 1 diabetes and coronary artery disease","volume":"29","author":"Orchard","year":"2006","journal-title":"Diabet. Care"},{"issue":"10","key":"10.1016\/j.diabres.2020.108591_b0010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001321","article-title":"Risk of cardiovascular disease and total mortality in adults with type 1 diabetes: Scottish registry linkage study","volume":"9","author":"Livingstone","year":"2012","journal-title":"PLoS Med"},{"issue":"25","key":"10.1016\/j.diabres.2020.108591_b0015","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1056\/NEJMoa052187","article-title":"Diabetes Control and Complications Trial\/Epidemiology of Diabetes Interventions and Complications (DCCT\/EDIC) Study Research Group. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes","volume":"353","author":"Nathan","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diabres.2020.108591_b0020","unstructured":"Diabetes Control and Complications Trial (DCCT)\/Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Group. Intensive diabetes treatment and cardiovascular outcomes in type 1 diabetes: The DCCT\/EDIC study 30-year follow-up. Diabetes Care 2016 Feb 9"},{"key":"10.1016\/j.diabres.2020.108591_b0025","doi-asserted-by":"crossref","unstructured":"Diabetes Control and Complications Trial (DCCT)-Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group, Nathan DM, Bebu I, Braffett BH, Orchard TJ, Cowie CC, Lopes-Virella M, Schutta M, Lachin JM. Risk factors for cardiovascular disease in type 1 diabetes. Diabetes 2016 Feb 19;65:1370-1379","DOI":"10.2337\/db15-1517"},{"issue":"7","key":"10.1016\/j.diabres.2020.108591_b0030","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.2337\/dc18-1613","article-title":"DCCT\/EDIC Research Group. Mediation of the effect of glycemia on the risk of CVD outcomes in type 1 diabetes: The DCCT\/EDIC study","volume":"42","author":"Bebu","year":"2019","journal-title":"Diabet Care"},{"issue":"10","key":"10.1016\/j.diabres.2020.108591_b0035","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1007\/s00125-017-4374-4","article-title":"DCCT\/EDIC Research Group. The relationship of blood glucose with cardiovascular disease is mediated over time by traditional risk factors in type 1 diabetes: The DCCT\/EDIC study","volume":"60","author":"Bebu","year":"2017","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabres.2020.108591_b0040","doi-asserted-by":"crossref","unstructured":"The DCCT Research Group. The diabetes control and complications trial (DCCT). design and methodologic considerations for the feasibility phase. Diabetes 1986 May;35(5):530-545","DOI":"10.2337\/diabetes.35.5.530"},{"key":"10.1016\/j.diabres.2020.108591_b0045","doi-asserted-by":"crossref","unstructured":"The DCCT\/EDIC Research Group. Epidemiology of diabetes interventions and complications (EDIC). design, implementation, and preliminary results of a long-term follow-up of the diabetes control and complications trial cohort. Diabetes Care 1999 Jan;22(1):99-111.","DOI":"10.2337\/diacare.22.1.99"},{"issue":"6","key":"10.1016\/j.diabres.2020.108591_b0050","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge","volume":"18","author":"Friedewald","year":"1972","journal-title":"Clin Chem"},{"issue":"7","key":"10.1016\/j.diabres.2020.108591_b0055","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.2215\/CJN.07901109","article-title":"DCCT\/EDIC Research Group. Comparison of urinary albumin-creatinine ratio and albumin excretion rate in the diabetes control and complications trial\/epidemiology of diabetes interventions and complications study","volume":"5","author":"Younes","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.diabres.2020.108591_b0060","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2337\/dc13-2116","article-title":"Update on cardiovascular outcomes at 30 years of the diabetes control and complications trial\/epidemiology of diabetes interventions and complications study","volume":"37","author":"Lachin","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2020.108591_b0065","unstructured":"Martinussen T, Scheike TH, Springer. Dynamic regression models for survival data 2006:470"},{"issue":"5","key":"10.1016\/j.diabres.2020.108591_b0070","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1097\/EDE.0b013e31825fa218","article-title":"Additive interaction in survival analysis: Use of the additive hazards model","volume":"23","author":"Rod","year":"2012","journal-title":"Epidemiology"},{"issue":"7","key":"10.1016\/j.diabres.2020.108591_b0075","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.2337\/dc10-0398","article-title":"Glycemic control and cardiovascular disease in 7,454 patients with type 1 diabetes: An observational study from the swedish national diabetes register (NDR)","volume":"33","author":"Eeg-Olofsson","year":"2010","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.diabres.2020.108591_b0080","doi-asserted-by":"crossref","first-page":"409","DOI":"10.2337\/db18-0515","volume":"68","author":"Miller","year":"2019","journal-title":"Diabetes"},{"issue":"9","key":"10.1016\/j.diabres.2020.108591_b0085","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.2337\/dc16-0502","article-title":"Coprogression of cardiovascular risk factors in type 1 diabetes during 30 years of follow-up in the DCCT\/EDIC study","volume":"39","author":"Writing Group for the DCCT\/EDIC Research Group","year":"2016","journal-title":"Diabet Care"},{"issue":"12","key":"10.1016\/j.diabres.2020.108591_b0090","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.2337\/dc16-2523","article-title":"DCCT\/EDIC Research Group. Impact of excessive weight gain on cardiovascular outcomes in type 1 diabetes: Results from the diabetes control and complications trial\/epidemiology of diabetes interventions and complications (DCCT\/EDIC) study","volume":"40","author":"Purnell","year":"2017","journal-title":"Diabet Care"},{"issue":"5","key":"10.1016\/j.diabres.2020.108591_b0095","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.freeradbiomed.2010.12.006","article-title":"Oxidative stress, insulin signaling, and diabetes","volume":"50","author":"Rains","year":"2011","journal-title":"Free Radic Biol Med"},{"issue":"20","key":"10.1016\/j.diabres.2020.108591_b0100","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1212\/WNL.0000000000001582","article-title":"White matter hyperintensities in middle-aged adults with childhood-onset type 1 diabetes","volume":"84","author":"Nunley","year":"2015","journal-title":"Neurology"},{"issue":"10","key":"10.1016\/j.diabres.2020.108591_b0105","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.2337\/dc20-0226","article-title":"DCCT\/EDIC Research Group. An observational study of the equivalence of age and duration of diabetes to glycemic control relative to the risk of complications in the combined cohorts of the DCCT\/EDIC study","volume":"43","author":"Bebu","year":"2020","journal-title":"Diabet Care"},{"issue":"3","key":"10.1016\/j.diabres.2020.108591_b0110","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1161\/CIRCULATIONAHA.106.634949","article-title":"Diabetic cardiovascular autonomic neuropathy","volume":"115","author":"Vinik","year":"2007","journal-title":"Circulation"},{"issue":"15","key":"10.1016\/j.diabres.2020.108591_b0115","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1001\/jama.2009.476","article-title":"Cardiac outcomes after screening for asymptomatic coronary artery disease in patients with type 2 diabetes: The DIAD study: A randomized controlled trial","volume":"301","author":"Young","year":"2009","journal-title":"JAMA"},{"issue":"23","key":"10.1016\/j.diabres.2020.108591_b0120","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1136\/heartjnl-2014-305657","article-title":"Peripheral neuropathy and the risk of cardiovascular events in type 2 diabetes mellitus","volume":"100","author":"Brownrigg","year":"2014","journal-title":"Heart"},{"issue":"10","key":"10.1016\/j.diabres.2020.108591_b0125","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/j.jacc.2019.03.009","article-title":"2019 ACC\/AHA guideline on the primary prevention of cardiovascular disease: Executive summary: A report of the american college of cardiology\/american heart association task force on clinical practice guidelines","volume":"74","author":"Arnett","year":"2019","journal-title":"J Am Coll Cardiol"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822720308482?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822720308482?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T19:16:18Z","timestamp":1759173378000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822720308482"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":25,"alternative-id":["S0168822720308482"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2020.108591","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Moderation of the effect of glycemia on the risk of cardiovascular disease in type 1 diabetes: The DCCT\/EDIC study","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2020.108591","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108591"}}